Response to 'Clinical and direct immunofluorescence characteristics of cutaneous toxicity associated with enfortumab vedotin': reply from the authors.

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

Penny, CL; Quow, K; Rundle, CW; Al-Rohil, RN; Cardones, AR; Kheterpal, MK; Fresco, AI

Published Date

August 2022

Published In

Br J Dermatol

Volume / Issue

187 / 2

Start / End Page

275 - 276

PubMed ID

35266142

Electronic International Standard Serial Number (EISSN)

1365-2133

Digital Object Identifier (DOI)

10.1111/bjd.21239

Language

eng

Conference Location

England